Nikko said that the funds raised were mainly used for the technological transformation of the production line of 1-aminoanthraquinone series products and comprehensive utilization of by-products, repaying bank loans and supplementing the Company's working capital. At the same time, technological transformation and project implementation is completed, the company will disperse all the dye industry chain opened up.

Financial data, the first half of 2016 Nikko biotechnology to achieve revenue of 161 million yuan, net profit of 31.16 million yuan.

Nikko biotechnology specializing in fine chemical Fluorescent Disperse Dyestuff products, biochemical products R & D, production and sales.